Neurogenic inflammation in allergen-challenged obese mice: A missing link in the obesity-asthma association

Experimental Lung Research

Volumn 38, Issue 6, 2012, Pages 316-324

  Ramalho, Renata ^a   Almeida, Joana ^b   Beltrão, Marília ^a   Pirraco, Ana ^a   Costa, Raquel ^a   Sokhatska, Oksana ^a   Guardão, Luísa ^a   Palmares, Carmo ^a   Guimarães, João Tiago ^a,b   Delgado, Luís ^a   Moreira, André ^a   Soares, Raquel ^a  

^a University of Porto   (Portugal)

^b POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

Author keywords

Asthma; Neurogenic inflammation; Obesity; Specific IgE; Substance P

Indexed keywords

ALLERGEN; GLUCOSE; IMMUNOGLOBULIN E; INSULIN; OVALBUMIN; SUBSTANCE P; TACHYKININ;

ALLERGIC AIRWAY INFLAMMATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EOSINOPHIL; HISTOPATHOLOGY; INFLAMMATORY CELL; INSULIN BLOOD LEVEL; INSULINEMIA; LUNG LAVAGE; MOUSE; NEUROGENIC INFLAMMATION; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; SERODIAGNOSIS;

ALLERGENS; ANIMALS; ASTHMA; BLOOD GLUCOSE; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; DIET, HIGH-FAT; IMMUNOGLOBULIN E; INSULIN; LUNG; MICE; MICE, INBRED BALB C; MICE, OBESE; NEUROGENIC INFLAMMATION; OBESITY; OVALBUMIN; SUBSTANCE P; TACHYKININS;

EID: 84862873156     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2012.699589     Document Type: Article

References (34)

1. Beuther DA, Sutherland ER: Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007;175(7):661-666
2. Farah C, Salome C: Asthma and obesity-a known association but unknown mechanism. Respirology. 2011; 14:412-421
3. Lessard A, Turcotte H, Cormier Y, Boulet LP: Obesity and asthma: a specific phenotype? Chest. 2008;134(2):317-323
4. Lugogo NL, Kraft M, Dixon AE: Does obesity produce a distinct asthma phenotype? J Appl Physiol. 2010 Mar;108(3): 729-734
5. Beuther DA: Recent insight into obesity and asthma. Curr Opin Pulm Med. 2010 Jan;16(1):64-70
6. Shore SA: Obesity and asthma: possible mechanisms. J Allerg Clinic Immun. 2008;121(5):1087-1093
7. Scott HA, Dibson PG, Garg ML, LG W: Airway inflammation is augmented by obesity and fatty acids in asthma. Eur Resp J. 2011;38(3):594-602
8. Farah CS, Kermode JA, Downie SR, Brown NJ, Hardaker KM, Berend N, et al.: Obesity is a determinant of asthma control, independent of inflammation and lung mechanics. Chest. 2011;140:659-666
9. Zhang Y, Berger A, Milne CD, Paige CJ: Tachykinins in the immune system. Curr Drug Targets. 2006;7(8):1011-1020
10. Groneberg D, Quarcoo D, Frossard N, Fisher A: Neurogenic mechanisms in bronchial inflammatory diseases. Allergy. 2004;59:1139-1152
11. Karagiannides I, Pothoulakis C: Substance P, obesity, and gut inflammation. Current Opinion in Endocrinology, Diabetes and Obesity. 2009;16(1):47-52
12. De Swert KO, Joos GF: Extending the understanding of sensory neuropeptides. Eur J Pharmacol. 2006 Mar 8;533(1-3): 171-181
13. Cima K, Vogelsinger H, Kahler CM: Sensory neuropeptides are potent chemoattractants for human basophils in vitro. Regul Pept. 2010 Feb 25;160(1-3):42-48
14. Gross K, Karagiannides I, Thomou T, Koon HW, Bowe C, Kim H, Giorgadze N, Tchkonia T, Pirtskhalava T, Kirkland JL, Pothoulakis C: Substance P promotes expansion of human mesenteric preadipocytes through proliferative and antiapoptotic pathways. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1012-G1019
15. Karagiannides I, Torres D, Tseng Y, Bowe C, Carvalho E, Espinoza D, Pothoulakis C, Kokkotou E: Substance P as a novel anti-obesity target. Gastroenterology. 2008;134(3):747-755.e1
16. Karagiannides I, Bakirtzi K, Kokkotou E, Stavrakis D, Gross Margolis K, Thomou T, Giorgadze N, Kirkland JL, Pothoulakis C: Role of substance P in the regulation of glucose metabolism via insulin signaling-associated pathways. Endocrinology. 2011
17. Fu J, Liu B, Liu P, Liu L, Li G, Wu B, Liu X.: Substance P is associated with the development of obesity, chronic inflammation and type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2011;119(3):177-181
18. Patterson R, Johnston B, Ardill J, Heaney L, McGarvey L: Increased tachykinin levels in induced sputum from asthmatic and cough patients with acid reflux. Thorax. 2007;62(468-469)
19. Chu HW, Kraft M, Krause JE, Rex MD, Martin RJ: Substance P and its receptor neurokinin 1 expression in asthmatic airways. J Allergy Clin Immunol. 2000 Oct;106(4):713-22
20. Hens G, Raap U, Vanoirbeek J, Meyts I, Callebaut I, Verbinnen B, Vanaudenaerde BM, Cadot P, Nemery B, Bullens DMA, Ceuppens JL, Hellings PW: Selective nasal allergen provocation induces substance P-mediated bronchial hyperresponsiveness. Am J Respir Cell Mol Biol. 2011 Apr;44(4):517-523
21. Barnes PJ: Neurogenic inflammation in the airways. Respir Physiol. 2001 Mar;125(1-2):145-154
22. Yamashita N: Animal models of asthma. Respiration and Circulation. 2008;56(9):887-892
23. Dinh QT, Mingomataj E, Quarcoo D, Groneberg DA, Witt C, Klapp BF, et al.: Allergic airway inflammation induces tachykinin peptides expression in vagal sensory neurons innervating mouse airways. Clinical and Experimental Allergy. 2005;35(6):820-825
24. Silveira PS, PalmaresMC, Delgado L: [Bronchoalveolar lavage: methodology and clinical application] (translated from Portuguese). Rev Port Pneumonol 1997;III(2):155-178
25. Cataldo DD, Tournoy KG, Vermaelen K, Munaut C, Foidart JM, Louis R, Noel A, Pauwels RA: Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am J Pathol. 2002 Aug;161(2):491-498
26. Soares R, Costa C: Oxidative stress, inflammation and angiogenesis in the metabolic syndrome. Soares R, Costa C, editors: Springer; 2009
27. Cohn L, Elias JA, Chupp GL: Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol. 2004;22: 789-815
28. Williams R, Zou X, Hoyle GW: Tachykinin-1 receptor stimulates proinflammatory gene expression in lung epithelial cells through activation of NF-kB via a Gq-dependent pathway. Am J Physiol-Lung C. 2007;292(2):L430-L437
29. Saraiva SA, Silva AL, Xisto DG, Abreu SC, Silva JD, Silva PL, Teixeira TP, Parra ER, Carvalho AL, Annoni R, Mauad T, Capelozzi VL, Silva PM, Martins MA, Rocco PR: Impact of obesity on airway and lung parenchyma remodeling in experimental chronic allergic asthma. Respir Physiol Neurobiol. 2011 Jul 31;177(2):141-148
30. Johnston RA, ZhuM, Rivera-Sanchez YM, Lu FL, ThemanTA, Flynt L, Shore SA: Allergic airway responses in obese mice. Am J Respir Crit Care Med. 2007 Oct 1;176(7):650-658
31. Brewer JP, Kisselgof AB,Martin TR: Genetic variability in pulmonary physiological, cellular, and antibody responses to antigen in mice. Am J Respir Crit Care Med. 1999 Oct;160(4): 1150-1156
32. Barros R, Moreira A, Fonseca J, Moreira P, Fernandes L, de Oliveira JF, et al.: Obesity and airway inflammation in asthma. Journal of Allergy and Clinical Immunology. 2006; 117(6):1501-1502
33. Krug N, Rabe KF: Animal models for human asthma: the perspective of a clinician. Current Drug Targets. 2008; 9(6):438-442
34. Ramalho R, Soares R, Couto N, Moreira A:. Tachykinin receptors antagonism for asthma: a systematic review. BMC Pulm Med. 2011 2 August;11:1-7